CymaBay Therapeutics Inc. (CBAY) stock is nearly perfect except the valuation

CymaBay Therapeutics Inc. (NASDAQ: CBAY) closed the day trading at $6.61 down -4.76% from the previous closing price of $6.94. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 979231 shares were traded. CBAY stock price reached its highest trading level at $6.99 during the session, while it also had its lowest trading level at $6.59.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.



For a better understanding of CBAY, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.20 and its Current Ratio is at 12.20. In the meantime, Its Debt-to-Equity ratio is 1.43 whereas as Long-Term Debt/Eq ratio is at 1.43.

Upgrades & Downgrades

On August 04, 2020, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $9 to $13.

On July 31, 2020, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $12.Piper Sandler initiated its Overweight rating on July 31, 2020, with a $12 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 06 when Shah Sujal bought 51,301 shares for $1.95 per share. The transaction valued at 100,037 led to the insider holds 171,301 shares of the business.

Stock Price History:

Over the past 52 weeks, CBAY has reached a high of $7.15, while it has fallen to a 52-week low of $1.67. The 50-Day Moving Average of the stock is 4.66, while the 200-Day Moving Average is calculated to be 3.46.

Shares Statistics:

Over the past 3-months, CBAY traded about 751.58K shares per day on average, while over the past 10 days, CBAY traded about 1.3M shares per day. A total of 87.80M shares are outstanding, with a floating share count of 80.92M. Insiders hold about 0.39% of the company’s shares, while institutions hold 76.30% stake in the company. Shares short for CBAY as of Oct 13, 2022 were 1.74M with a Short Ratio of 3.71M, compared to 1.32M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.06% and a Short% of Float of 2.44%.

Earnings Estimates

Current recommendations for the stock of the company come from 9 analysts. On average, analysts expect EPS of -$0.3 for the current quarter, with a high estimate of -$0.25 and a low estimate of -$0.34, while EPS last year was -$0.33. The consensus estimate for the next quarter is -$0.28, with high estimates of $0.01 and low estimates of -$0.36.

Analysts are recommending an EPS of between -$0.94 and -$1.36 for the fiscal current year, implying an average EPS of -$1.22. EPS for the following year is -$1.26, with 8 analysts recommending between -$0.78 and -$1.41.